# Glutamine for the Treatment of Patients With Irritable Bowel Syndrome

> **NCT01414244** · PHASE2 · COMPLETED · sponsor: **Tulane University** · enrollment: 106 (actual)

## Conditions studied

- Diarrhea-Predominant Irritable Bowel Syndrome

## Interventions

- **DRUG:** Glutamine

## Key facts

- **NCT ID:** NCT01414244
- **Lead sponsor:** Tulane University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2015-12-30
- **Final completion:** 2015-12-30
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2017-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01414244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01414244, "Glutamine for the Treatment of Patients With Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01414244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*